Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Blepharoplasty, also known as an eyelid surgery, eye lift, eyelid lift is a type of surgery that repairs droopy eyelids and may involve removing excess skin, muscle and fat. Blepharoplasty is one of the most commonly performed facial cosmetic procedures. Symptoms such as tired-looking eyes, excess skin, droopy eyelids, or circles around the eyes may benefit from blepharoplasty. It can also be combined with other facial and skin rejuvenation procedures such as brow or mid-face lift, lasers or chemical skin resurfacing.
The global blepharoplasty treatment market is experiencing high demand due to rise in consciousness about beauty and enhancing aesthetic appeal. Rising consumer awareness pertaining to their beauty, physical grooming, and aesthetics has led to high demand for blepharoplasty treatment. In recent scenario, consumers are highly concerned about their physical appearance. With rise in disposable income, spending on personal care is also increasing. Blepharoplasty treatment reduces or eliminates the peripheral vision problems, which propel the demand for the blepharoplasty treatment in the aged people and drives the growth of the global blepharoplasty treatment market. However, expensive operative procedures and side effects associated with the treatments are hampering the market.
The report analyses the global blepharoplasty treatment market based on surgery type, indication, technology, gender, end user and geography.
Based on surgery type, the market is categorized into upper eyelid surgery, combination eyelid surgery and lower eyelid surgery. While upper blepharoplasty can be considered a purely cosmetic procedure in many patients, the procedure is functional of nature as well and provides the solution for patients that suffer from dermatochalasis-related symptoms of heavy and tired eyelids, nagging headache and even loss of vision. Moreover, transconjunctival blepharoplasty is indicated in young patients with baggy eyes, puffiness and dark circles under eyes with no skin wrinkles and in Hyperthyroid patients. It can be combined with skin rejuvenation.
Various indications of the blepharoplasty treatment are chronic puffiness of the upper eyelids, drooping lower eyelids, eye bags & wrinkles in the lower eyelids and sagging skin of the upper eyelids.
The technologies studied in this market majorly include surgical; and non-surgical technologies such as, Botox, injectable dermal fillers, laser treatments and radiofrequency. AGNES is a non-surgical tightening treatment that targets loose, baggy skin over, under and around the eyes. Using radiofrequency, the treatment melts fat accumulations on the upper eyelids and under eyes, while stimulating collagen growth in the underlying skin. The combination approach lifts and reduces drooping eyelids and eyebags, while tightening and minimizing fine lines over the entire eye area.
Furthermore, based on gender, the market is segmented into female and male. In the United States, more than 16 percent of blepharoplasties are performed on men. Male tend to seek out blepharoplasty more for functional reasons than women, but this difference has become less and less distinct in recent years. Blepharoplasty treatment is one the most popular trends in cosmetic industry over the past few years especially in the age group of 40 to 50.
The end user of this market are hospitals, ophthalmic clinics, ambulatory surgical centres and others. Overall, patients prefer less invasive outpatient procedures that can be performed in dermatology clinics, instead of hospital procedures that would potentially require anaesthesia. Minimally invasive laser treatments for blepharoplasty are capitalizing on this trend and represent the fastest-growing market worldwide.
By geography, the global blepharoplasty treatment market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America followed by Europe will continue to dominate the global blepharoplasty treatment market. North America has surfaced as the key contributor to the global market due to soaring interest of consumers in personal grooming, coupled with their high purchasing power that makes them capable of affording expensive blepharoplasty procedures. Moreover, growth in popularity of blepharoplasty treatment and availability of skilled dermatologists in European countries are some of the factors anticipated to foster the regional demand. Also, the Asia Pacific is expected to exhibit significant growth over the forecast period due to increasing disposable income and demand for cost-effective blepharoplasty procedures. Rising beauty consciousness in developing countries is also anticipated to create growth opportunities in the untapped markets of APAC.
The leading blepharoplasty treatment market players are Advance Medical Systems Inc., ThermiGen LLC., Agnes, GTG Wellness Sdn. Bhd, Grand Aespio Inc., Dana Co. Ltd., Bomtech Electronics Co., Ltd., Luminera Derm Ltd, Re-Aesthetic Limited and Levadent Ltd. among others. The growing investments in research and development of cosmetic industry have been encouraging the market players to offer effective solutions to gain a competitive edge in the blepharoplasty treatment market.
The global blepharoplasty treatment market is segmented based on surgery type, indication, technology, gender, end user and geography. Based on surgery type, the market is categorized into upper eyelid surgery, combination eyelid surgery and lower eyelid surgery.
Various indications of the blepharoplasty treatment are chronic puffiness of the upper eyelids, drooping lower eyelids, eye bags & wrinkles in the lower eyelids and sagging skin of the upper eyelids.
The technologies studied in this market majorly include surgical; and non-surgical technologies such as, Botox, injectable dermal fillers, laser treatments and radiofrequency. AGNES is a non-surgical tightening treatment that targets loose, baggy skin over, under and around the eyes.
Furthermore, based on gender, the market is segmented into female and male. In the United States, more than 16 percent of blepharoplasties are performed on men. The end user of this market are hospitals, ophthalmic clinics, ambulatory surgical centres and others.
By geography, the global blepharoplasty treatment market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America followed by Europe will continue to dominate the global blepharoplasty treatment market.
Why to buy this report:
